As an additional validation of our experimental approach’s ability to capture biologically relevant effects, we were interested in examining the impact of IBD-associated variants in the known IBD causal gene IFIH1 in our HT-29 model. The gene discussed is IFIH1; the disease is inflammatory bowel disease.